Apr 11, 2024, 13:50
New blood test predicts clinical benefit to IO AND identifies which patient will develop toxicity by Jarushka Naidoo – LUNGevity Foundation
LUNGevity Foundation shared on X/Twitter:
“50% patients develop side effects from immunotx. New blood test predicts clinical benefit to IO AND identifies which patient will develop toxicity and require proactive monitoring. Important question esp for PD-L1>50% Great presentation by Jarushka Naidoo. AACR24″
Source: LUNGevity Foundation/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 9, 2024, 09:25
Oct 9, 2024, 08:29
Oct 9, 2024, 08:23
Oct 9, 2024, 08:16